Timber Pharmaceuticals Announces NYSE Acceptance Of Plan To Regain Listing Compliance
Portfolio Pulse from Benzinga Newsdesk
Timber Pharmaceuticals has announced that the New York Stock Exchange (NYSE) has accepted its plan to regain listing compliance. This comes after the company was previously at risk of being delisted due to non-compliance with NYSE's listing standards.
September 18, 2023 | 8:08 pm
News sentiment analysis
Sort by:
Ascending
POSITIVE IMPACT
Timber Pharmaceuticals' plan to regain listing compliance has been accepted by NYSE. This could potentially stabilize the company's stock price in the short term.
The acceptance of Timber Pharmaceuticals' plan by NYSE removes the immediate threat of delisting, which could have led to a significant drop in the company's stock price. This news is likely to be seen positively by investors, potentially leading to a short-term increase in the stock price.
CONFIDENCE 90
IMPORTANCE 80
RELEVANCE 100